Armistice Capital, LLC 13D and 13G filings for Catalyst Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:27 pm Sale | 2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | Armistice Capital, LLC | 0 0.000% | -9,572,000 (Position Closed) | Filing |
| 2022-02-14 6:28 pm Sale | 2021-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | Armistice Capital, LLC | 9,572,000 9.300% | -428,000 (-4.28%) | Filing |
| 2021-02-16 2:59 pm Purchase | 2020-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | Armistice Capital, LLC | 10,000,000 9.700% | 4,622,000 (+85.94%) | Filing |